Evidence map›Paper›PMID 25883673›Full record

ReviewEvidence-based complementary and alternative medicine : eCAM2015

Advances in the research and development of natural health products as main stream cancer therapeutics.

Pamela Ovadje, Alessia Roma, Matthew Steckle, Leah Nicoletti, John Thor Arnason, Siyaram Pandey

Abstract readReview
In one paragraph

Review in Evidence-based complementary and alternative medicine : eCAM, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Evaluation of Anticancer Potential ofAntioxidants (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Review
  5. Hydroalcoholic extract ofVeterinary research forum : an international quarterly journal · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. EMODIN DOWNREGULATES CELL PROLIFERATION MARKERS DURING DMBA INDUCED ORAL CARCINOGENESIS IN GOLDEN SYRIAN HAMSTERS.African journal of traditional, complementary, and alternative medicines : AJTCAM · 2017
    Article
  19. Anticancer Effects of Sinocrassulosides VI/VII fromEvidence-based complementary and alternative medicine : eCAM · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pamela OvadjeDepartment of Chemistry & Biochemistry, University of Windsor, Windsor, ON, Canada.
Alessia RomaDepartment of Chemistry & Biochemistry, University of Windsor, Windsor, ON, Canada.
Matthew SteckleDepartment of Chemistry & Biochemistry, University of Windsor, Windsor, ON, Canada.
Leah NicolettiDepartment of Chemistry & Biochemistry, University of Windsor, Windsor, ON, Canada.
John Thor ArnasonDepartment of Biology, University of Ottawa, Ottawa, ON, Canada.
Siyaram PandeyDepartment of Chemistry & Biochemistry, University of Windsor, Windsor, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural health products (NHPs) are defined as natural extracts containing polychemical mixtures; they play a leading role in the discovery and development of drugs, for disease treatment. More than 50% of current cancer therapeutics are derived from natural sources. However, the efficacy of natural extracts in treating cancer has not been explored extensively. Scientific research into the validity and mechanism of action of these products is needed to develop NHPs as main stream cancer therapy. The preclinical and clinical validation of NHPs would be essential for this development. This review summarizes some of the recent advancements in the area of NHPs with anticancer effects. This review also focuses on various NHPs that have been studied to scientifically validate their claims as anticancer agents. Furthermore, this review emphasizes the efficacy of these NHPs in targeting the multiple vulnerabilities of cancer cells for a more selective efficacious treatment. The studies reviewed here have paved the way for the introduction of more NHPs from traditional medicine to the forefront of modern medicine, in order to provide alternative, safer, and cheaper complementary treatments for cancer therapy and possibly improve the quality of life of cancer patients.

Identifiers

PMID25883673
PMCPMC4391654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.